Maher Kurdi

411 total citations
45 papers, 270 citations indexed

About

Maher Kurdi is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maher Kurdi has authored 45 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 18 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maher Kurdi's work include Glioma Diagnosis and Treatment (20 papers), Brain Metastases and Treatment (7 papers) and Alzheimer's disease research and treatments (4 papers). Maher Kurdi is often cited by papers focused on Glioma Diagnosis and Treatment (20 papers), Brain Metastases and Treatment (7 papers) and Alzheimer's disease research and treatments (4 papers). Maher Kurdi collaborates with scholars based in Saudi Arabia, Canada and United States. Maher Kurdi's co-authors include Badrah S. Alghamdi, Fahad S. Alshehri, Saleh Baeesa, Ahmed K. Bamaga, Nadeem Shafique Butt, Yasser Alatawi, Lee Cyn Ang, Robert Hammond, Shadi Alkhayyat and Fawaz Siddiqi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Maher Kurdi

43 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maher Kurdi Saudi Arabia 8 72 62 50 43 33 45 270
You Jeong Park United States 11 50 0.7× 98 1.6× 13 0.3× 32 0.7× 18 0.5× 19 277
Blaise Cozene United States 11 54 0.8× 120 1.9× 16 0.3× 38 0.9× 18 0.5× 15 282
Pundit Asavaritikrai Thailand 5 59 0.8× 120 1.9× 20 0.4× 55 1.3× 5 0.2× 9 408
Erick Gómez‐Apo Mexico 9 37 0.5× 76 1.2× 7 0.1× 74 1.7× 32 1.0× 25 343
Shengtao Yao China 11 32 0.4× 159 2.6× 40 0.8× 29 0.7× 26 0.8× 19 414
Brian P. Lemkuil United States 7 60 0.8× 97 1.6× 49 1.0× 49 1.1× 10 0.3× 12 371
Antoine Anfray United States 10 26 0.4× 104 1.7× 35 0.7× 105 2.4× 19 0.6× 16 459
Candace Rossignol United States 12 23 0.3× 97 1.6× 121 2.4× 17 0.4× 6 0.2× 20 387
Elizaveta B. Boitsova Russia 7 22 0.3× 95 1.5× 13 0.3× 67 1.6× 33 1.0× 15 318

Countries citing papers authored by Maher Kurdi

Since Specialization
Citations

This map shows the geographic impact of Maher Kurdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher Kurdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher Kurdi more than expected).

Fields of papers citing papers by Maher Kurdi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maher Kurdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher Kurdi. The network helps show where Maher Kurdi may publish in the future.

Co-authorship network of co-authors of Maher Kurdi

This figure shows the co-authorship network connecting the top 25 collaborators of Maher Kurdi. A scholar is included among the top collaborators of Maher Kurdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maher Kurdi. Maher Kurdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurdi, Maher, et al.. (2024). Mitochondrial DNA Alterations in Glioblastoma and Current Therapeutic Targets. Frontiers in Bioscience-Landmark. 29(10). 367–367. 2 indexed citations
2.
Kurdi, Maher, et al.. (2024). Glioblastoma with PRMT5 gene upregulation is a key target for tumor cell regression. ONCOLOGIE. 26(2). 239–246. 4 indexed citations
3.
4.
5.
6.
Mehboob, Riffat, et al.. (2022). Immunolocalization of neurokinin 1 receptor in WHO grade 4 astrocytomas, oral squamouscell and urothelial carcinoma. Folia Neuropathologica. 60(2). 165–176. 7 indexed citations
7.
Kurdi, Maher, et al.. (2022). Association Between CD204-Expressed Tumor-Associated Macrophages and MGMT-Promoter Methylation in the Microenvironment of Grade 4 Astrocytomas. World Journal of Oncology. 13(3). 117–125. 4 indexed citations
8.
9.
Mehboob, Riffat, Maher Kurdi, Syed Amir Gilani, et al.. (2021). Comprehensive Analysis of Genes Associated With Sudden Infant Death Syndrome. Frontiers in Pediatrics. 9. 742225–742225. 4 indexed citations
10.
Alshehri, Fahad S., et al.. (2021). Melatonin Improves Short-Term Spatial Memory in a Mouse Model of Alzheimer’s Disease. PubMed. Volume 11. 15–27. 23 indexed citations
11.
12.
Alghamdi, Badrah S., et al.. (2021). Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer’s disease. Behavioural Brain Research. 402. 113100–113100. 66 indexed citations
13.
14.
15.
Kurdi, Maher, Badrah S. Alghamdi, Jeremy Parfitt, & Lee Cyn Ang. (2021). Globular glial tauopathy, a newly recognized white matter tauopathy, with depression/anxiety disorder: report and review of classification. Folia Neuropathologica. 59(1). 98–103. 2 indexed citations
16.
Mehboob, Riffat, et al.. (2021). Substance P/ Neurokinin-1 Receptor, Trigeminal Ganglion, Latency, and Coronavirus Infection-Is There Any Link?. Frontiers in Medicine. 8. 727593–727593. 11 indexed citations
17.
Kurdi, Maher & Badrah S. Alghamdi. (2020). Is granulovacuolar degeneration an essential pathologicalcomponent of Alzheimer’s disease? A review of the pathogenesisand histochemistry of old studies. Folia Neuropathologica. 58(4). 277–286. 2 indexed citations
18.
Kurdi, Maher, et al.. (2016). De novo glioblastoma in the territory of a recent middle cerebral artery infarction and a residual meningioma: pathogenesis revisited. World Journal of Surgical Oncology. 14(1). 112–112. 7 indexed citations
19.
Kurdi, Maher & David A. Ramsay. (2016). Balo's concentric lesions with concurrent features of Schilder s disease in relapsing multiple sclerosis: neuropathological findings. Autopsy and Case Reports. 6(4). 21–26. 1 indexed citations
20.
Kurdi, Maher, Yong Wang, Baraa K. Al‐Khazraji, et al.. (2014). CT Perfusion Imaging as an Early Biomarker of Differential Response to Stereotactic Radiosurgery in C6 Rat Gliomas. PLoS ONE. 9(10). e109781–e109781. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by You Jeong Park Breakdown of academic impact, for papers by Blaise Cozene Breakdown of academic impact, for papers by Pundit Asavaritikrai Breakdown of academic impact, for papers by Erick Gómez‐Apo Breakdown of academic impact, for papers by Shengtao Yao Breakdown of academic impact, for papers by Brian P. Lemkuil Breakdown of academic impact, for papers by Antoine Anfray Breakdown of academic impact, for papers by Candace Rossignol Breakdown of academic impact, for papers by Elizaveta B. Boitsova
Rankless by CCL
2026